By the medical analyses, the patient resulted therefore suffering from panhypopituitarism and being treated with growth hormone, presenting concomitant SMMCI with exclusion of the co-presence of holoprosencephaly (as evident from postnatal MRI where only a reduced pituitary was highlighted). The gene discussed is GH1; the disease is holoprosencephaly.